CINXE.COM

<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" /> <meta charset="utf-8" /><script type="text/html" id="sf-tracking-consent-manager"> <style> /*Consent Form*/ #tracking-consent-dialog { padding: 15px; position: fixed; bottom: 0; right: 5px; width: 337px; border: 3px solid #1e82e0; border-radius: 5px 5px 0px 0px; background: rgba(255, 255, 255, .95); font-size: 16px; z-index: 999; } #tracking-consent-dialog-accept { background-color: #1e82e0; color: #fff; font-size: 16px; font-weight: 500; float: right; } .consent-close { font-weight: bold; float: right; padding: 2px 7px; right: 6px; top: 3px; cursor: pointer; font-size: 11px; position: absolute; background-color: #1e82e0; color: #fff; z-index: 999; border-radius: 50%; } @media (max-width: 767px) { #tracking-consent-dialog { width: 100%; font-size: 14px; } } </style> <div id="tracking-consent-dialog"> <div class="consent-close" onclick="TrackingConsentManager.updateUserConsent(true)">X</div> Cookie Policy CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our <a href="https://www.cambridgeinnovationinstitute.com/Privacy-Policy/">Privacy Policy</a> for more information. <button type="button" onclick="TrackingConsentManager.updateUserConsent(true)" id="tracking-consent-dialog-accept" class="btn btn-default">Continue</button> </div> </script><script type="text/javascript" src="/WebResource.axd?d=DzHrpQl5URXarFHAtrmzFrNeeCwCLwHK2gvGZ95fW9WnidZLXrfDlGTuxUr3l463ttkzDVh9D8Bug9pu7NHdr_V4jKJPpR5aBflu4f8Ts5edKoXW2sH8LcSZSfqlYNJ5LpoUn5WBE_fdKcz0yNVMxY3w_4XLcip6ESbZeM3DDdUqeeNFFCEiKQKGKqR186oo0&t=637922505220000000"> </script> <script src="/ScriptResource.axd?d=okuX3IVIBwfJlfEQK32K3iZZtiInnD21Q3naS01thH9-fzUaksT1ZtMUjWfsR2IfFrdwuSgx30ngwb9MjfyLwf8qicr33ktg3mwcpW2o3dsDH8d3-t4otTq9qT-5mrFfzK1f5nCn185AY5nCZScdoqJ1WOdlA_-4T4B_v3AbufPsc2J5Jr9-kOiHGAB_hap-0&t=4e1c7b51" type="text/javascript"></script><script src="/ScriptResource.axd?d=EydukmxBmDstn7gSYzQESGX1Bc6SUabUViYB9LpdmFW6eZLmGFNo26FA-YqkH5f3QjtPWjAHxth32_ExmLGGY1zv6AdaQenYAqaM29qW1bTxx1r5T--aFytKsL9IQMjnWBhhM3Ox0iMnCMCJK5xrzQardvmrid9DGkma-HwbE57flKsxZSkIFbT-h8oEIp2m0&t=4e1c7b51" type="text/javascript"></script><link href="/ResourcePackages/Bootstrap/assets/dist/css/main.min.css" rel="stylesheet" type="text/css" /><link href="/css/global.css" rel="stylesheet" type="text/css" /><link href="/css/editor.css" rel="stylesheet" type="text/css" /> <link href="//fonts.googleapis.com/css?family=Roboto:500,400,700" rel="stylesheet" type="text/css"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no" /> <meta property="og:image" content="/images/librariesprovider8/template-images/23/pge-og-1200x627.jpg" /><meta property="og:title" content="Poster Titles | PEGS Europe | 14-16 November 2022" /><meta property="og:description" content="View the poster titles at PEGS Summit Europe to explore the newest research in biopharma from around the globe. " /><meta property="og:url" content="https://www.pegsummiteurope.com/poster-titles" /><meta property="og:type" content="website" /><meta property="og:site_name" content="Pegs Summit Europe" /><link href="/css/24/pge/style-pge.css" media="all" rel="stylesheet" type="text/css" /><script type="text/javascript"> var link = document.createElement('link'); link.id = 'dynamic-favicon'; link.rel = 'shortcut icon'; link.href = '/images/librariesprovider8/template-images/21/favicon.png'; document.head.appendChild(link); </script><script type="text/javascript"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MZXW9KK'); </script><meta name="Generator" content="Sitefinity 14.2.7900.0 DX" /><link rel="canonical" href="https://www.pegsummiteurope.com/poster-titles" /><script type="application/json" id="sf-insight-metadata"> {"contentMetadata":"{\"Id\":\"6545f6d9-50d6-4f87-89f8-0384fed7b864\",\"ContentType\":\"Page\",\"Title\":\"Poster Titles\",\"CanonicalTitle\":\"Poster Titles\",\"CanonicalUrl\":\"https://www.pegsummiteurope.com/poster-titles\",\"CreatedOn\":\"2018-10-16T14:10:14Z\",\"ModifiedOn\":\"2024-11-04T17:00:40Z\",\"SiteName\":\"Pegs Summit Europe\",\"PageId\":\"6545f6d9-50d6-4f87-89f8-0384fed7b864\"}","videosMetadata":"[]"} </script><script type="application/json" id="sf-insight-settings"> {"apiServerUrl":"https://api.insight.sitefinity.com/","apiKey":"62dc77b5-9fbc-74c6-8f79-d05463f0565e","applicationName":"CII_DEC","trackingCookieDomain":"","keepDecTrackingCookieOnTrackingConsentRejection":false,"slidingExpirationForTrackingCookie":false,"maxAgeForTrackingCookieInDays":365,"trackYouTubeVideos":true,"strategy":"Persist|False","docsHrefTestExpressions":[".*\\/docs\\/.+\\.{1}.+((\\?|\\\u0026)sfvrsn=.+){1}$",".+((\\?|\\\u0026)sf_dm_key=.+){1}$"]} </script><script type="text/javascript" src="/WebResource.axd?d=HtQyXelCu6mzSPcVcvK_BrDGcMZ2eaAwTGCTL_5l9xvo0iV9h2YYkvXanQ1uf0LidxbxWd8AzxNrppPmU7C9KnzDV98eKbg88D2zgKyY_GVq-IK4cwpq3ApmVVQHZ20G6_cSyVvbsc3d7cEOVVpoZalFAGFOo2fFcbG9u0riPX3ha1PNvfZCNU2C8dj5lXB2aevtM9BprQUEvuhENe--svD7i9F-8WutvDj5rAfLCkI1&t=637922505220000000"> </script><script src="https://cdn.insight.sitefinity.com/sdk/sitefinity-insight-client.min.3.1.7.js" async="async"> </script><link href="/Telerik.Web.UI.WebResource.axd?d=PMrIT5dOWaVYIcpFWUE4nCGcRFDqtHj8a0dT9N7jtPAWgyp5t5fff0pvXeFargWg3kuRljuyyjKW8grLvrafOr9X0kIEdj24q9AbiZ0prs7qITvLoGQxdqYfpMFPSD250&t=638628063619626917&compress=0&_TSM_CombinedScripts_=%3b%3bTelerik.Sitefinity.Resources%2c+Version%3d14.2.7900.0%2c+Culture%3dneutral%2c+PublicKeyToken%3db28c218413bdf563%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3a7a90d6a" type="text/css" rel="stylesheet" /><title> Poster Titles | PEGS Europe | 14-16 November 2022 </title></head> <body><form method="post" action="./poster-titles" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="ctl04_TSM" id="ctl04_TSM" value="" /> <input type="hidden" name="ctl05_TSSM" id="ctl05_TSSM" value="" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="K6HOrs/44UHtfgHb6mUSakdPO+a7NrGHakOlKoOalBmBynJPRGJE3gZJgapWkHNVFnN4cYGmVWJWzuZk+W+z3fxbJ+jaT9aA+WUkdh+C0xs=" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=pynGkmcFUV13He1Qd6_TZA_YQJD9xSUnUi70uTXUUGkw9zf_LlVkiouvQJnBXeCn1svgT4yxk9LfN7iuqrWtXg2&t=638628063619783110" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var __cultureInfo = {"name":"en","numberFormat":{"CurrencyDecimalDigits":2,"CurrencyDecimalSeparator":".","IsReadOnly":true,"CurrencyGroupSizes":[3],"NumberGroupSizes":[3],"PercentGroupSizes":[3],"CurrencyGroupSeparator":",","CurrencySymbol":"$","NaNSymbol":"NaN","CurrencyNegativePattern":0,"NumberNegativePattern":1,"PercentPositivePattern":1,"PercentNegativePattern":1,"NegativeInfinitySymbol":"-∞","NegativeSign":"-","NumberDecimalDigits":2,"NumberDecimalSeparator":".","NumberGroupSeparator":",","CurrencyPositivePattern":0,"PositiveInfinitySymbol":"∞","PositiveSign":"+","PercentDecimalDigits":2,"PercentDecimalSeparator":".","PercentGroupSeparator":",","PercentSymbol":"%","PerMilleSymbol":"‰","NativeDigits":["0","1","2","3","4","5","6","7","8","9"],"DigitSubstitution":1},"dateTimeFormat":{"AMDesignator":"AM","Calendar":{"MinSupportedDateTime":"\/Date(-62135578800000)\/","MaxSupportedDateTime":"\/Date(253402300799999)\/","AlgorithmType":1,"CalendarType":1,"Eras":[1],"TwoDigitYearMax":2049,"IsReadOnly":true},"DateSeparator":"/","FirstDayOfWeek":0,"CalendarWeekRule":0,"FullDateTimePattern":"dddd, MMMM d, yyyy h:mm:ss tt","LongDatePattern":"dddd, MMMM d, yyyy","LongTimePattern":"h:mm:ss tt","MonthDayPattern":"MMMM d","PMDesignator":"PM","RFC1123Pattern":"ddd, dd MMM yyyy HH\u0027:\u0027mm\u0027:\u0027ss \u0027GMT\u0027","ShortDatePattern":"M/d/yyyy","ShortTimePattern":"h:mm tt","SortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd\u0027T\u0027HH\u0027:\u0027mm\u0027:\u0027ss","TimeSeparator":":","UniversalSortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd HH\u0027:\u0027mm\u0027:\u0027ss\u0027Z\u0027","YearMonthPattern":"MMMM yyyy","AbbreviatedDayNames":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"ShortestDayNames":["Su","Mo","Tu","We","Th","Fr","Sa"],"DayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"AbbreviatedMonthNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthNames":["January","February","March","April","May","June","July","August","September","October","November","December",""],"IsReadOnly":true,"NativeCalendarName":"Gregorian Calendar","AbbreviatedMonthGenitiveNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthGenitiveNames":["January","February","March","April","May","June","July","August","September","October","November","December",""]},"eras":[1,"A.D.",null,0]};//]]> </script> <script src="/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_=ctl04_TSM&compress=0&_TSM_CombinedScripts_=%3b%3bSystem.Web.Extensions%2c+Version%3d4.0.0.0%2c+Culture%3dneutral%2c+PublicKeyToken%3d31bf3856ad364e35%3aen%3a95047a2c-8908-49e3-b68e-d249be89f134%3aea597d4b%3ab25378d2" type="text/javascript"></script> <script src="/ScriptResource.axd?d=oBrf1f-DLFBYf_XnAiQIerYbp6DB1yP-XX6e2f1MfVZVh0-b8UJuYKCCtCgeTZdgs__r0fZWEGLHIbAdafwt8M9e685ZdEjP_79w8Op8pqlhtK8RVD9yvuuHQYso7wAeipQsr1KNKlxF-82gFsHvkROGzjmcQ59FFLTFjwumrh-7zfhoHiIXFsqfCwU3VcIw0&t=4e1c7b51" type="text/javascript"></script> <script src="/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_=ctl04_TSM&compress=0&_TSM_CombinedScripts_=%3b%3bTelerik.Sitefinity.Resources%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3ab162b7a1" type="text/javascript"></script> <script src="/Frontend-Assembly/Telerik.Sitefinity.Frontend/Mvc/Scripts/Bootstrap/js/bootstrap.min.js?package=Bootstrap&v=MTQuMi43OTAwLjA%3d" type="text/javascript"></script> <script src="/js/sgs/menu-wsub.js" type="text/javascript"></script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="973FB29F" /> </div><script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$ctl04', 'aspnetForm', [], [], [], 90, 'ctl00'); //]]> </script> <input type="hidden" name="ctl00$ctl04" id="ctl04" /> <script type="text/javascript"> //<![CDATA[ Sys.Application.setServerId("ctl04", "ctl00$ctl04"); Sys.Application._enableHistoryInScriptManager(); //]]> </script> <iframe id="__historyFrame" src="/ScriptResource.axd?d=xoncwwLIowChO63aEREcXixGFfs8Yc6KeZ0Vx9dI4n1zGKHPvqOh539cawySD_JUaJ_0Zq2JWeFYkflynA2lXUhzZuwKDQhmJ1Gf-sh25vDHuNUSRuWBVI1gnyesKGQ8BvasBNcuKRaIr6rwU3JhFQ2" style="display:none;"> </iframe> <div> <div class="navbar navbar-default navbar-fixed-top"> <a class="navbar-brand large" href="/"></a> <div class="navbar-header"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse"> </button> </div> <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"> <ul class="nav navbar-nav large-nav" role="menu"> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Agenda </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/programs" target="_self">Programs</a> </li> <li class=""> <a href="/speaker-biographies" target="_self">Speaker Biographies</a> </li> <li class=""> <a href="/keynote" target="_self">Keynotes</a> </li> <li class=""> <a href="/Top-Pharma" target="_self">Top Biopharma</a> </li> <li class=""> <a href="/short-courses" target="_self">Short Courses</a> </li> <li class=""> <a href="/PEGS-Europe-Training-Seminars" target="_self">Training Seminars</a> </li> <li class=""> <a href="/attendee-list" target="_self">Attendee List</a> </li> <li class=""> <a href="/agenda/search-agenda" target="_self">Search Agenda</a> </li> <li class=""> <a href="/testimonials" target="_self">Testimonials</a> </li> <li class=""> <a href="/networking" target="_self">Networking</a> </li> <li class=""> <a href="/archives" target="_self">Archives</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Sponsor/Exhibit </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/sponsor" target="_self">Attendee Demographics + Event Features</a> </li> <li class=""> <a href="/sponsorship-opportunities" target="_self">Sponsorship Opportunities</a> </li> <li class=""> <a href="/sponsors" target="_self">Current Sponsors</a> </li> <li class=""> <a href="/sponsorship-prospectus-form" target="_self">Sponsorship Prospectus</a> </li> <li class=""> <a href="/docs/librariesprovider8/sponsor-and-exhibit/24/pge24-floorplan.pdf" target="_blank">Current Exhibitors/Floorplan</a> </li> <li class=""> <a href="https://www.intheorious.com/chi/pub/pge2025b_pub/" target="_blank">2025 Re-sign Floorplan</a> </li> <li class=""> <a href="/exhibit-services-schedule" target="_self">Exhibit Services/Schedule</a> </li> <li class=""> <a href="http://www.healthtech.com/Lead-Gen/" target="_blank">Lead Generation Opportunities</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Downloads </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/brochures" target="_self">Brochures</a> </li> </ul> </li> <li class=""><a href="/travel" target="_self">Travel </a></li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Posters </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/posters" target="_self">Poster Information</a> </li> <li class="active"> <a href="/poster-titles" target="_self">Poster Titles</a> </li> </ul> </li> <li class=""><a href="http://www.healthtech.com/press.aspx" target="_blank">Press</a></li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Register </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/reg/pge" target="_self">Individual Pricing</a> </li> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/reg/pge/group" target="_self">Group Pricing</a> </li> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/reg/pge/ondemand" target="_self">On Demand Pricing</a> </li> </ul> </li> </ul> </div> </div> </div> <div > <div class="sf-Long-text" ><div class="mobile-header hidden-sm hidden-md hidden-lg"><a href="/"><img class="imageResize" src="/images/librariesprovider8/template-images/24/header-mob.png?sfvrsn=992d3334_1" alt="PEGS Summit Europe" /></a> </div></div> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MZXW9KK" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="main-content"> <div id="cph1" class="container internal"> <div class="row"> <div class="row" data-sf-element="Row"> <div class="col-sm-9"> <div id="Contentplaceholder1_T14051A0F003_Col00" class="sf_colsIn pad-lr" data-sf-element="Column 1" data-placeholder-label="Column 1"> <div > <div class="sf-Long-text" >2024 Poster Presentations  Poster Awards: Poster Session A Winner Announced Wednesday at 10:45; Poster Session B Winner Announced Thursday at 13:30 POSTER SESSION A: Tuesday - Wednesday (morning)*Posters 001-011 will be in both Poster Sessions and available Wednesday only.*A001: Glyoxal Agarose as the Best Alternative for Covalent Antibody Coupling in Affinity Chromatography, Presented by Yaiza L., Agarose Bead Technologies*A002: IgBlend: Unifying 3D Structure and Sequence for Antibody LLMs, Presented by Cedric M., AstraZeneca*A003: Novel LCMS-Compatible icIEF Fractionation for Characterization of Innovator and Biosimilar mAbs, Presented by Jean-Francois B., Bio-Techne*A004: Advancing Drug Discovery Using mMPS High-Throughput Synthesis Technology to Elevate Variant Library Precision, Presented by Ming D., GCATbio Co., Ltd.*A005: Biology42: Generative Biologics Is an Advanced, AI-Powered Platform that Is Capable of Designing and Optimizing Different Types of Biologics, Including Peptides, Nanobodies, and Antibodies Tailored for Specific Targets, Presented by Andrei A., Insilico Medicine AI*A006: K-One® Innovative Surface Chemistry: Revolutionizing Chip Functionalization and SPR Analysis of Biotherapeutics, Presented by Nicolas H., Kimialys*A007: Unlocking Anakinra’s Potential: PEGylation for Prolonged Stability and Chain-length Modulation, Presented by Isilay G., Koc University*A008: Broadly Inhibitory Human Monoclonal Antibodies Against Duffy Binding Protein II Variants Elicited by Natural Plasmodium vivax Infection, Presented by Piyawan K., Mahidol University*A009: Combination of Peptide Mapping Analysis and SPR-Based Binding Kinetic to Identify Methionine Oxidation and Its Effect on the Biological Activity of IgG1 Antibody, Presented by Elvira L., Menarini Biotech S.r.l.*A010: In Vivo Reprogramming of CAR-T Cells with LNP-Circular RNA Technology, Presented by Jing Z., Therorna, Inc.*A011: A Clickable Antibody Design to Generate Antibody-Drug Conjugates (ADCs) in a Trojan Horse Manner, Presented by Nathanael R., Universitat Ramon LlullA012: Real-Time Kinetics on Cells and Further Analytical Tools to Avoid the Translational Gap, Presented by Vera M., 2bind GmbHA013: New Epitope Mapping Combines Single Amino Acid Resolution and High Throughput: SEQITOPE, Revolutionizing the Antibody Selection Process, Presented by Mats P., AAX Biotech ABA014: Discovering Site-Specific Antibodies Against Challenging Targets Using the Epivolve Platform, Presented by Troy L., AbbraTech, Inc.A015: Biophysical Methodologies for the QC of Abcam Rabbit Monoclonal Antibodies (RabMAb®) and Proteins, Presented by Fiona T., Abcam plcA016: Discovery of Diverse GPCR-Targeted Antibodies Using Integrated Technologies, Presented by Romain R., AbCellera AustraliaA017: Plug-and-Play Approach to Stabilize scFv Fragment Antibodies, Presented by Greg D., AC ImmuneA018: Accelerating the Development of Novel Antibody-Drug Conjugates Through Site-Specific Conjugation Methods, Presented by Hengshuo L., ACROBiosystemsA019: Analysis of NIST mAb Reference Material by Parallel SDS-Capillary Electrophoresis, Presented by Xuemei L., Agilent TechnologiesA020: Enhancing the Cytotoxicity of Immunotoxins by Facilitating Their Dissociation from Target Receptors Under the Reducing Conditions of the Endocytic Pathway, Presented by Byeong-Ho C., Ajou UniversityA021: ANV600 Is a Novel PD-1 Targeted IL-2Rß/γ Agonist that Is Combinable with Therapeutic PD-1 Inhibitors, Presented by Christian S., Anaveon AGA022: CIS Display 2.0: An In Vitro Display Technology for Complex Microprotein Discovery, Presented by Duncan M., Applied Biomedical Science InstituteA023: Leap-In Transposases® - A New Standard in Cell Line Development, Presented by Mario P., ATUMA024: Rapid Generation of Bispecific Antibodies for High-Throughput Screening with SpyLock Technology, Presented by John C., Bio-Rad LaboratoriesA025: TrailBlazer: A Rapid Modular Antibody Assembly Platform, Presented by Sophie M., Bio-Rad LaboratoriesA026: Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform, Presented by Paul R., Bio-Rad LaboratoriesA027: Separation of Bispecific-Antibody Related Impurities with Mixed-Mode Chromatography, Presented by Artur S., Bio-Rad LaboratoriesA028: Characterization of the FcRn-Doppelmab Interaction via a Combination of Affinity Chromatography and Mass Spectrometry, Presented by Miriam E., Boehringer Ingelheim Pharma GmbH & Co. KGA029: High-Throughput Protein Quality Attribute Monitoring During Biotherapeutics Development by MALDI-MS, Presented by Christopher l., Boehringer Ingelheim Pharma GmbH & Co. KGA030: TheraPRO® CHO Media System: Achieve High Productivity in CHOK1SV GS-KO® Cell Lines with Our Advanced Formulated, Easy-to-Use Media and Feed Solution, Presented by Joke S., Lonza Benelux BVA031: Formulation Development - New Platform Concept, Presented by Mihaela S,, Boehringer Ingelheim Pharma GmbH & Co. KGA032: Going Beyond Binary Hit Generation with Opto® B Discovery Affinity Assay on the Beacon® Optofluidic System, Presented by Tiago S., BrukerA033: Digital Control of Expression for Rapid, High-Titer Production of Complex Products in CHO Cells, Presented by Laura D., CatalentA034: Tumbler: A Highly Customizable Antibody Optimization Suite, Presented by Brad G., Charles River LaboratoriesA035: Retrogenix® Express Off-Target Panel: Rapid Early Assessment of Off-Target Binding in Phage Display Platforms, Presented by Diogo R., Charles River LaboratoriesA036: Rapid Immunogenicity Screening of Antibody Therapeutics via Human CD4+ T Cell IL-2 Secretion, Presented by Yoshiyuki A., Chugai Pharmaceutical Co., Ltd.A037: Drug Product Oriented mAb Developability Assessment Combining Biophysical Characterization and Benchmarking to Commercial Products, Presented by Kristian L., Coriolis PharmaA038: Automated Image Analysis AI Model of Ice Crystal Growth for Optimization of Annealing in Lyophilization, Presented by Kanako M., Daiichi Sankyo Co., Ltd.A039: Developing Protein Engineering for Defence and Security, Presented by Josh P., Defence Science and Technology Laboratory (Dstl)A040: Antibody Characterization Before Cloning Is the Key: Advanced DIANA HTS Monoclonal Antibody Discovery Pipeline, Presented by Klara K., DIANA Biotechnologies, a.s.A041: Improving Biopharmaceutical Processes Through Raman Spectroscopy-Driven Automated Monitoring and Control, Presented by Lydya AM., Endress+HauserA042: Droplet Microfluidic Antibody Screening Platform for Functional Antibodies at the Single-Cell Level, Presented by Leonie K., EPFL - Swiss Federal Institute of Technology LausanneA043: CD2 BiTco: Novel CD2-Targeted Bispecific T Cell Co-Stimulators for Cancer Immunotherapy, Presented by Welbeck D., Evotec International GmbHA044: Mytomab: Multi-Specific Cytotoxicity Maximizing Antibodies for Cancer Immunotherapy, Presented by Gerhard N., Evotec International GmbHA045: Use of Drosophila S2 Cells for Production of Highly Immunogenic Antigens, Presented by Max S., ExpreS2ion BiotechnologiesA046: Accelerating Antibody Discovery and Development to the Clinic with Proprietary Mammalian Display, Presented by Cleide F., FairJourney Biologics SAA047: FcRN Binding Assessment of IgG Fc Variants: A 360° View with Affinity, Kinetics and In Vitro Testing, Presented by Rita M., FairJourney Biologics SAA048: Continuous Titration Based Method for Rapid In-Solution Analysis of Non-Covalent Interactions, Presented by Philipp W., Fida Biosystems ApSA049: Ab-ility™ - An In-Silico Analysis and Developability Engineering Platform, Presented by Britney A., Fusion Antibodies plcA050: Integrated Analysis of Assays Drives Early Developability Assessment of Antibodies, Presented by Miguelangel CV., Genedata AGA051: End-To-End Software Platform for Streamlined LC/MS-Based Multi-Attribute Method (MAM) Implementation, Presented by Catherine E., Genedata AGA052: A Digital Platform to Automate Production, Optimization, and Evaluation of Viral and Non-Viral Vectors for Cell and Gene Therapy, Presented by Sebastian K., Genedata AGA053: Automatic Assignment of Biacore SPR and Octet BLI Kinetic Binding Curve Profiles with Artificial Intelligence, Presented by Maija P., Genedata AGA054: Antibody and Therapeutics Discovery: Network and Tree Visualizations for Interrogating Sequence Similarity Between Unique Clones and CDRs in NGS Datasets, Presented by Evan S., Geneious by DotmaticsA055: High Throughput Expression Strategies for Protein Complexes, Presented by Angita S., GlaxoSmithKlineA056: Developing Pineal Cell Lines for Sleep Drug Screening, Presented by Hong L., Humetacell Co., Ltd.A057: Purification of In Vivo Biotinylated Proteins by Using Strep-Tactin®XT, Presented by Philipp H., IBA Lifesciences GmbHA058: Development of Therapeutic Antibodies Targeting the GLUT1 Transporter to Restrict Cancer Cell Growth, Presented by Lauri P., IcosagenA059: BTN2A1 Targeting Reprograms M2-Like Macrophages and TAMs via SYK and MAPK Signaling, Presented by Carla C., ImCheck TherapeuticsA060: Immunotoxicity Assessment of Clinical Antibodies Using an Ex Vivo Circulating Human Whole Blood Assay with Low Anticoagulants, Presented by Laura R., Immuneed ABA061: Generate Your Single-Domain Antibodies (VHH) in 6 Weeks Using AI and Biological Tools, for Impactful Research, Presented by Philippe H., ImmunochemA062: Optimizing Discovery Strategies for TCR Bispecific, Presented by Sam E. & Peter M., Immunocore Ltd.A063: Site-Specific Integration of Transgenes into CHO Cells Using Landing Pads, Presented by Tobias M., InSCREENeX GmbHA064: Site-Directed Cysteine Conjugation of Disulfide-Rich Non-Antibody Carrier Proteins (THIOCAPs) for Targeted Cancer Therapies, Presented by Ugutz U., Institut de Recerca Sant Pau (IIB St Pau)A065: Lipoparticles (VLPs) Present Native-Conformation Membrane Proteins, Enabling Antibody Discovery, Presented by Ross C., Integral MolecularA066: Specificity Testing of Antibodies, Multispecifics, and CAR-T Therapeutics for IND Using the Membrane Proteome Array, Presented by Rachel F., Integral MolecularA067: Replacing Live Virus in Bioassays – Reporter Virus Particles (RVPs), Presented by Ileine S., Integral MolecularA068: Unleashing the Power of MHC-Associated Peptide Proteomics: Immunogenicity Assessment of Biotherapeutics, Presented by Sofie P., IQVIA LaboratoriesA069: Synergistic Effect of Human-Like Monoclonal Antibodies in Poxvirus Protection, Presented by Hadas T., Israel Institute for Biological ResearchA070: In-Silico Solutions for Accelerated and Enhanced Antibody Discovery and Development, Presented by Marianne BS., JSR Life SciencesA071: Tailored AAV Solutions: AAV ELISA Kits and Customized Variant Kit Development, Presented by Yujiao Z., KactusBio, Inc.A072: Comprehensive and Reliable Characterization of Antibody Therapeutics Thanks to K-One® Powered Innovative SPR Biochips, Presented by Adrien A., KimialysA073: Highly Efficient Capture of Circulating and Tissue-Infiltrating B Cell Repertoires from Multiple Species: Kling-Select, Presented by Casper M., Kling Biotherapeutics BVA074: Kling-Evolve as a Tool for Rapid Response to Emerging Variants and Pandemic Preparedness: Directed Evolution of Variant-Specific Antibody from Immortalized B Cells, Presented by Casper M., Kling Biotherapeutics BVA075: Rational Design and Optimization of an IL-6 Binding Nanobody Through CDR Grafting and Mutagenesis, Presented by Chandana S., Korea Research Institute of Bioscience and BiotechnologyA076: Design of an Affibody-Peptide Fusion for Inhibition of Sortilin-Mediated Progranulin Degradation, Presented by Moira E., KTH Royal Institute of TechnologyA077: A Drop of Insight: Single Cell Functional Profiling for Immunotherapy, Presented by Simon M., LightcastA078: Identification of Next-Generation Brain Shuttles and Shuttle Targets and Using Multiplexed In Vivo Screening with Protein Barcodes, Presented by Karen D., Manifold BioA079: Visualizing Antibody-Receptor Interactions at Single-Protein Resolution with RESI, Presented by Isabelle P., Max Planck Institute of BiochemistryA080: MHC MACSimers Combine Flexibility, Quality and Releasability for the Detection of Ag-Specific T Cells, Presented by Marek W., Miltenyi Biotec B.V. & Co. KGA081: Combination Screening Approaches of Novel Synthetic Single Domain Antibody Library, Presented by Cameron S., Monash UniversityA082: Development of a ‘Switchable’ Yeast for Antibody Discovery, Presented by David I., Neochromosome, Inc.A083: Optimization of pIX Phage Display for Improved Discovery of Human TCR-Like Antibodies, Presented by Goril B. & Terje F., Nextera ASA084: A Novel icIEF and Digital SPR Workflow for Correlating the Charge Structure to the Function of a Bispecific Antibody, Presented by Anja M., Nicoya LifesciencesA085: Single Domain CD3 Antibody Enables Next-Generation T Cell Engagers for Enhanced Immunotherapies, Presented by Xiangyu R., Nona BiosciencesA086: Pre-Clinical Validation of Humanized Bicistronic CAR T Cells Against CCR9 and CD1a for the Treatment of Relapsed/Refractory T-Cell Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma (T-ALL/LL), Presented by Alba GP., OneChain ImmunotherapeuticsA087: Using Mammalian Display to Mature Anti-AGelD187N Antibody for Subcutaneous Delivery, Presented by Laura L., Orion CorporationA088: Developability Assessment for Nonspecificity and Polyspecificity in High-Throughput Bead-Based Assays in Microplates, Presented by Sebastian G., PAIA Biotech GmbHA089: Imaging Mass Cytometry Reveals the Spatial Network of Immune Cells in Neuroblastoma, Presented by Francisca B., Prinses Maxima CentrumA090: A Game of Hide and Seek: Targeting Neuroblastoma's Escape from Immunotherapy, Presented by Beatrice P., Prinses Maxima CentrumA091: Development of Bioluminescent No-wash Fc Gamma Receptor Binding Immunoassay to Guide the Development of Antibody Therapeutics, Presented by Kai H., Promega CorporationA092: Improved Analytical Methodologies for the Characterization of Biosimilars, Presented by Michael R., Promega CorporationA093: Advancements in Multi-Protein Quantitation for Host Cell Protein Discovery, Presented by Stephane B., Protein Metrics by DotmaticsA094: A Middle-Level Approach to Simplify Sample Preparation and Data Analysis for Characterization of the Fusion Protein Blinatumomab, Presented by Lucy F., Protein Metrics by DotmaticsA095: Digested Oligonucleotide IP-RPLC-MS/MS Characterization of mRNA Sequence, 5’ Cap, and 3’ PolyA Tail, Presented by David L., Protein Metrics by DotmaticsA096: Advancing Antibody Engineering and Maturation with High-Throughput Single-Molecule Imaging System, Presented by Booyoung Y., PROTEINA Co., Ltd.A097: Structural Basis for the FLAG/Anti-FLAG M2 Interaction, Presented by Matti P., QVQ Holdings B.V.A098: Improving Antibody Fragment Expression in Escherichia coli for the Generation of Smart Targeted Therapeutics, Presented by Montserrat ER., Ramon Llull UniversityA099: Optimizing a Mammalian Cell-Free Expression System Using Design of Experiments, Presented by Maximilian G., RWTH Aachen UniversityA100: Novel Human and Murine Monoclonal Antibodies Targeting CDH17 in Tumors, Presented by Sherry C., Sanyou Biopharmaceuticals, Inc.A101: Protein-Based Therapeutics: Leveraging NMR for Formulation Optimization, Quality Control, and Biosimilar Development, Presented by Anais N., SARomics Biostructures ABA102: Verification of the Unique Functionality of ATOR-1017 by 3D Structure Determination, Presented by Megan S., SARomics Biostructures ABA103: Ace06, a Fully Human CLC BCMA/GPRC5D/CD3 Trispecific TCE Targeting Multiple Myeloma, Presented by Jinghua G., Shanghai AceMab Biotechnology Ltd.A104: Fully Human DLL3/CD3 TCEs with Excellent Killing Potency Against Small Cell Lung Cancer (SCLC) Cells, Presented by See Heng W., Shanghai AceMab Biotechnology Ltd.A105: Gen 3 Platforms and Affinity Maturation, Presented by Andrew B., Specifica, an IQVIA businessA106: In Vitro Approaches to Developing pH Antibodies, Presented by Andrew B., Specifica, an IQVIA businessA107: Potency-Attenuated Analogues of PNU-159,682 Provide GlycoConnect™/HydraSpace® ADCs with Improved Tolerability and Therapeutic Index, Presented by Marcel S., Synaffix - A Lonza companyA108: Construction and Characterization of Affibody-scFv Fusion Proteins Targeting FKBP51, Presented by Viktoria H., Technical University of DarmstadtA109: The Effect of Target Specifying Protein Fusion on the Functionality of Anti-CD20-Based Tetravalent Bispecific Biologics, Presented by Omer G. & Dor I., Tel Aviv UniversityA110: Accelerating Discovery and Rational Engineering of Antibody Modalities Using Cryo-Electron Microscopy, Presented by Ieva D., Thermo Fisher ScientificA111: Structural Basis for Activity Enhancement of Cancer Bispecific Antibody by Domain Rearrangement Revealed by Cryo-EM, Presented by Yoshikazu T., Tohoku UniversityA112: Design of Prodrug T Cell Engaging Bispecific Antibodies Employing T Cell Activation Molecules as Masks, Presented by Ryutaro A., Tokyo University of Agriculture and TechnologyA113: Conformational Epitope Mapping of the Major Peanut Allergens, Presented by Almog B., Ukko, Inc.A114: Development of Single-Domain Antibodies with Fluorescent and Luminescent Properties Using the Pichia pastoris Expression System, Presented by Aina G., Universidad Complutense de MadridA115: Development of a Novel Naïve scFv Rabbit Library, Presented by Santiago R., Universidad Complutense de MadridA116: A Novel Family of Cleavable Linkers for Antibody-Drug Conjugates, Presented by Indrealie LP., Universite de StrasbourgA117: A Novel Lentiviral Production System to Minimise Transgene Expression in Producer Cells, Presented by Luke T., University College LondonA118: AI-Based Protein Design and Validation, Presented by Bianca B., University Hospital BonnA119: CDCP1 - A Novel Target for CAR-T Cell Therapy in Prostate Cancer, Presented by Franziska S., University Hospital BonnA120: Applying Nanobody-Based Strategies in the Precision Therapy of Urological Cancers, Presented by Miriam S., University Hospital BonnA121: Impact of Sequence Representation on Machine Learning Models of Protein Expression, Presented by Yuxin S., University of EdinburghA122: Gb3-Targeting Lectibodies in Cancer Therapy, Presented by Jana T., University of FreiburgA123: Pore-Forming Proteins: Can They Be Engineered to Selectively Form Pores on a Target Membrane?, Presented by Xiangling C., University of GroningenA124: Exploring a Novel Enzyme Collection for Tumor Desialylation of Human Breast Cancer and Feline Mammary Carcinoma, Presented by Magda F., University of LisbonA125: Development of TROP-2-Targeting Recombinant Antibody-PROTAC Conjugates for Triple-Negative Breast Cancer, Presented by Rafaela M., University of LisbonA126: Targeted Desialylation of Tumor Cells: Unlocking a Novel Immunotherapeutic Approach, Presented by Alexandra O., University of LisbonA127: Spreadsheet DoE: A Tool for Optimising Protein Production and Characterisation, Presented by Elliott S., University of LiverpoolA128: Prediction of Concentration-Dependent Antibody Properties Using Interpretable Machine Learning, Presented by Na Young K., University of MichiganA129: Design and Functional Characterization of Novel scFv× VHH Format of Biparatopic Antibody Against MtsA from Streptococcus pyogenes, Presented by Risa A., University of TokyoA130: Improving Mammalian Display Through Inclusion of IRES, Presented by Saara O., University of TurkuA131: Accelerating Drug Development by Molecular Imaging: Conjugation of Biomolecules for In Vivo Optical and Nuclear Imaging, Presented by Janik P., Vrije Universiteit BrusselA132: VDU: A (Pre)GMP Facility for Small Scale Production of Biomolecules in Pichia pastoris, Presented by Hilde R., Vrije Universiteit BrusselA133: Complementary Light Scattering Solutions for Protein Characterization, Presented by Nicolas M., Waters CorporationA134: Towards Completely Computational Antibody Optimization, Presented by Ariel T., Weizmann Institute of ScienceA135: Construction of Branched VHHs Complex Using SpyCatcher/Tag System, Presented by Koki M., Yamagata UniversityA136: Utilization of Precise Mutagenesis Library (PML) and High-Throughput (HTP) Fast Screening of Expression Biophysical-Properties Affinity (FASEBA) Screening Platform to Achieve High Affinity by Affinity Maturation, Presented by Payal R., ProBio, a subsidiary of GenScript Biotech CorporationA137: Utilization of Naïve VHH Phage Display Library and Integrated Antibody Engineering Platform to Generate Antibody Leads for CAR-T Therapy, Presented by Payal R., ProBio, a subsidiary of GenScript Biotech CorporationA138: Transgenic Llama Mice - A Fast and Flexible Single Domain Discovery Tool, Presented by Friedrich KN., GenovacA139: Formulation Development of an HIV-Vaccine Protein, Presented by Mauricio M., NanoTemper Technologies Ltd.A140: Predict Side Effect of Anti-CD28 Agonist Nanobodies In Silico, Presented by Yifei L., Technical University of DarmstadtV1: Nanobody Tools for the Capture and Analysis of Cytokines and Immunoglobulins, Presented by Christian LW., ChromoTek GmbHV2: Nanobody-Based Tools for In-Depth Research of Immuno-Oncology Targets, Presented by Sabrina W., ChromoTek GmbH POSTER SESSION B: Wednesday (afternoon) – Thursday*Posters 001-011 will be in both Poster Sessions and available Wednesday only. *B001: Glyoxal Agarose as the Best Alternative for Covalent Antibody Coupling in Affinity Chromatography, Presented by Yaiza L., Agarose Bead Technologies*B002: IgBlend: Unifying 3D Structure and Sequence for Antibody LLMs, Presented by Cedric M., AstraZeneca*B003: Novel LCMS-Compatible icIEF Fractionation for Characterization of Innovator and Biosimilar mAbs, Presented by Jean-Francois B., Bio-Techne*B004: Advancing Drug Discovery Using mMPS High-Throughput Synthesis Technology to Elevate Variant Library Precision, Presented by Ming D., GCATbio Co., Ltd.*B005: Biology42: Generative Biologics Is an Advanced, AI-Powered Platform that Is Capable of Designing and Optimizing Different Types of Biologics, Including Peptides, Nanobodies, and Antibodies Tailored for Specific Targets, Presented by Andrei A., Insilico Medicine AI*B006: K-One® Innovative Surface Chemistry: Revolutionizing Chip Functionalization and SPR Analysis of Biotherapeutics, Presented by Nicolas H., Kimialys*B007: Unlocking Anakinra’s Potential: PEGylation for Prolonged Stability and Chain-length Modulation, Presented by Isilay G., Koc University*B008: Broadly Inhibitory Human Monoclonal Antibodies Against Duffy Binding Protein II Variants Elicited by Natural Plasmodium vivax Infection, Presented by Piyawan K., Mahidol University*B009: Combination of Peptide Mapping Analysis and SPR-Based Binding Kinetic to Identify Methionine Oxidation and Its Effect on the Biological Activity of IgG1 Antibody, Presented by Elvira L., Menarini Biotech S.r.l.*B010: In Vivo Reprogramming of CAR-T Cells with LNP-Circular RNA Technology, Presented by Jing Z., Therorna, Inc.*B011: A Clickable Antibody Design to Generate Antibody-Drug Conjugates (ADCs) in a Trojan Horse Manner, Presented by Nathanael R., Universitat Ramon LlullB012: FAST - Enabling the Rapid Discovery and Creation of GPCR Agonist Antibodies, Presented by Monica S., Abalone BioB013: EpiScreen® 2.0 Immunogenicity Assays Utilizing EdU Proliferation and Activation Marker Analysis Provide Sensitive, Data-Rich Immunogenicity Assessments, Presented by Pearce C., AbzenaB014: Development of a Platform Approach to Identify the Most Functional and Developable Bispecific T-Cell Engager, Presented by Christopher S., AbzenaB015: TROCEPT: A Unique Adenovirus for In-Tumour Expression of Immunotherapies via Intravenous Delivery, Presented by Rita F., Accession Therapeutics Ltd.B016: Overcoming Cell Line Development Inefficiencies and Streamlining the Clone Selection Process for Protein Biologic Production with the Solentim Ecosystem, Presented by Adam C., Advanced InstrumentsB017: Engineering Bispecific T-Cell Engagers to Deplete Eosinophils for the Treatment of Severe Eosinophilic Asthma, Presented by Seul-Gi L., Ajou UniversityB018: Active Learning for Affinity Prediction of Antibodies, Presented by Alexandra G., AstraZenecaB019: Exploring Log-Likelihood Scores for Ranking Antibody Sequence Designs, Presented by Talip U., AstraZenecaB020: Automated Clone Screening System, Presented by Lutz E., Beckman Coulter Life SciencesB021: Simple and Rapid Analytics for Protein Titer and Aggregation, Presented by Eligio I., Beckman Coulter Life SciencesB022: Semi-Automated Extraction of Cell and Tissue Samples for Multi-Omic Analysis Using the Biomek i7 Hybrid Workstation, Presented by Antonia K., Beckman Coulter Life SciencesB023: Implementing Sustainability in mAb Purification Workflows, Presented by Jean-Francois D., Bio-Rad LaboratoriesB024: Viscosity Prediction of High-Concentration Antibody Solutions from All-Atom MD Simulations, Presented by Michaela B., Boehringer Ingelheim Pharma GmbH & Co. KGB025: Polyoxyethylene Fatty Ethers as Alternative Surfactants in Biotherapeutic Formulations, Presented by Stefan C., Boehringer Ingelheim Pharma GmbH & Co. KGB026: Formulatability Assessment to Evaluate Platform Fit of Molecules for Formulation Development, Presented by Kristina K., Boehringer Ingelheim Pharma GmbH & Co. KGB027: Complex Protein Format Development: A Deep Dive into Understanding Impact on Process Development, Presented by Petra V., Boehringer Ingelheim Pharma GmbH & Co. KGB028: HT-SPR Evaluation of Fc Gamma Receptor Binding Using Carterra LSA-XT, Presented by Christian G., Carterra, Inc.B029: Large-Scale Characterization of Drug Candidates Against Transmembrane Receptors Using HT-SPR, Presented by Andrew G., Carterra, Inc.B030: Phagekine Directed Evolution: Discovery and Optimization of Interleukin-2-Derived Immunotherapeutics, Presented by Gertrudis R., Center of Molecular ImmunologyB031: Constrained Peptide Modeling, Conformational Analysis and Property Predictions, Presented by Purvi G., Chemical Computing GroupB032: Structure-Based Charge Calculations for Predicting Properties and Profiling Antibody Therapeutics, Presented by Nels T., Chemical Computing GroupB033: Crowdsourcing Targets for Antibody Panning: Depositing NGS Data into the Public Domain, Presented by Harmen V., Cradle BioB034: A Streamlined Drug Discovery Platform for the Production and Characterization of Protein Biologics and Antigens, Presented by Kevin S., CRELUX, a WuXi AppTec CompanyB035: Epitope Mapping Case Studies by Deep Mutational Scanning, Presented by Hugo G., DeeptopeB036: Modulation of Antibodies' Fc Fragment Interaction with Fc Receptors by Deep Mutational Scanning, Presented by Fabien Q., DeeptopeB037: Discovery and Characterization of Biased Agonist and Antagonist Anti-hCCR5 Antibodies Using 3rd Generation ebBRET Biosensors, Presented by Guilhem D., Domain Therapeutics NA, Inc.B038: Real-Time Screening of Protein Stability at Liquid-Liquid Interfaces in a Microfluidic Device, Presented by Dominik Z., ETH ZurichB039: Optimization of Antibody Production: A Study Using Nalgene 5L Angled Bottom Shake Flasks with the ExpiCHO Expression System, Presented by Silvana A., FairJourney Biologics SAB040: Antibody Discovery and Characterization: A Multidimensional Approach for Next-generation Therapeutics, Presented by Joana Q., FairJourney Biologics SAB041: Machine Learning Guided Interaction Analysis, Presented by Sean D., Fluidic Sciences Ltd.B042: Establishment of Rabbit Monoclonal Antibodies Against Membrane Proteins Using New Single B Cell Screening Technology, Presented by Albert Z., FUJIFILM Wako Chemicals Europe GmbHB043: Harnessing the Synergy Between Biophysics and Structural Biology to Drive Drug Discovery, Presented by Leopold T., Galapagos NVB044: Effect of N-Terminal Amino Acid Sequence on the Protein Synthesis Using a Reconstituted Cell-Free Protein Synthesis System, Presented by Takashi K., GenefrontierB045: Optimizing Antibody Lead Identification: A High Throughput Sequencing and Synthesis Solution, Presented by Hans H., GENEWIZ from Azenta Life SciencesB046: Rapid Quality Assessment of Therapeutic Monoclonal Antibodies Through Automated Middle-Level Mass Spectrometry, Presented by Kristina S., GenovisB047: A Novel Enzyme for Efficient Digestion of Hinge-Mutated Antibodies, Presented by Philip W., GenovisB048: Leveraging GenScript’s DNA Mutant Libraries for AI-Based Epitope-Specific Antibody Drug Design, Presented by Xing G., GenScript USA, Inc.B049: Targeted Delivery of IL-2 to CD8[+] T Cells by GI-108 via Cis-Binding Mechanism Enhances Anti-Tumor Immunity Through the Expansion of Tumor-Specific CD8[+] T Cells, Presented by Kayoung S., GI InnovationB050: Membrane, Resin, and Impact to Product: Overcoming Barriers to Adopting Membrane Technology by Demonstrating Protein A Affinity Capture Step Product Quality and Process Characteristic Similarity, Presented by Jeffrey C., W. L. Gore & Associates, Inc.B051: ML-Guided Epitope Steering and Antibody Optimization with Mammalian Display Generates a Diverse Panel of CD3 T-Cell Engagers, Presented by Martin b., iBio, Inc.B052: Development of a High-Titer Bi-Paratopic Tetravalent Diabody-Fc-Fab: Using the IcoCell® Line, Design for Manufacturability and Modern DoE, Presented by Ilja G., IcosagenB053: Managing Discovery and Early Characterization Workflows of T Cell Receptors for Biotherapeutic Use in an Integrated Data System, Presented by Lina B., Immatics Biotechnologies GmbHB054: Affinity Maturation of a TCR Targeting the Tumor Stroma Antigen COL6A3 Increases Sensitivity and Specificity, Presented by Thomas T., Immatics Biotechnologies GmbHB055: High Throughput Epitope Mapping and Screening in Live Cells, Presented by Hetal M., Immuto ScientificB056: ANTIPASTI: Interpretable Prediction of Antibody Binding Affinity Exploiting Normal Modes and Deep Learning, Presented by Kevin M., Imperial College LondonB057: STEAP1 Targeting CAR-T Cells Locally Expressing Collagen-Binding IL-12 for Advanced Prostate Cancer, Presented by Koichi S., Imperial College LondonB058: Preferred Left-Handed Conformation of Glycyls at Pathogenic Sites, Presented by Purva M., Indian Institute of Science Education and Research, MohaliB059: Enhanced Plasmid Production: Achieving a 21-Fold Increase in Plasmids per Liter with 88.5% Supercoiled DNA, Presented by David LP., Infors AGB060: Accelerating VHH Lead Candidate Panel Generation Through High-Throughput Early Triaging of Optimal B Cell Clones, Presented by Arthur K., IPA (ImmunoPrecise Antibodies)B061: Amplifying the Therapeutic Potential of Rabbit-Derived Antibodies by an Advanced, Multi-Parametric Humanization Approach for Single-Step Engineering, Presented by Ilse R., IPA (ImmunoPrecise Antibodies)B062: Pharmacokinetic Profiling of Albumin-Associated Drugs Using a Humanized Mouse Model with Human Albumin and FcRn, Presented by Adriano F., Jackson LaboratoryB063: Next-Generation Humanized Models for Evaluating Immunomodulatory Molecules In Vivo, Presented by Ralph G., Jackson LaboratoryB064: Humanized FcRn Models to Assess the Pharmacokinetic Profile of Therapeutic Antibodies, Presented by Philip G., Jackson LaboratoryB065: Transforming Tumor Research: Engineering MHCs as Versatile Reagents, Presented by Xiaoyuan R., KactusBio, Inc.B066: GPCR VLPs & Nanodiscs for Drug Discovery, Presented by ManHee S., KactusBio, Inc.B067: The FUT8 KO SURE CHO-M Cell Line™ for Production of Afucosylated Therapeutic Antibodies, Presented by Louis D., KBI BiopharmaB068: New Transposase Integration in SUREtechnology Platform™ Takes High-Performance Clones to the Next-Level, Presented by Eva G., KBI BiopharmaB069: Recombinant Production of Bovine Serum Albumin (BSA) in Yeast, Presented by Matilde D., Levprot BioscienceB070: Exploiting Auto-Induction by Carbon Source Limitation to Improve Space-Time-Yields of Recombinant Protein Production in E. coli, Presented by Karlheinz F., LonzaB071: Novel Synthetic Production Phase Promoter for Enhanced Titre, Product Quality and Expression Stability in CHO Cells, Presented by Yusuf J., LonzaB072: Clone-Wise Biomarker Discovery Enabled Through Single-Cell RNA Sequencing, Presented by Pavle V., LonzaB073: A Novel IL23R-IL12R Cytokine Switch Receptor for Solid Tumor Cell Therapy, Presented by Dominic S., Ludwig Maximilians UniversityB074: An Afucosylated Monoclonal Antibody Increases In Vitro Opsonophagocytic Killing of Enterococcus faecalis Bacteria, Presented by Enisa S., Ludwig Maximilians UniversityB075: Case Study: Assessing Innovator vs. Biosimilar mAb Stability to Minimize Immunogenic Risk, Presented by Edward F., Malvern PanalyticalB076: Next-Generation Bioanalytical Instrument for Drug Discovery and Life Sciences, Presented by Amanda P., Malvern PanalyticalB077: Unleashing the Power of Perfusion: A Breakthrough in Cell Line Development for Intensified Processes, Presented by Vincent B., MilliporeSigmaB078: Effect of Transport and Storage on the Stability of Endometrial Cancer Biomarkers in Processed and Unprocessed Uterine Aspirate Samples, Presented by Javier C., MiMARK DiagnosticsB079: A Method for High-Throughput Screening of Monoclonal Antibody Internalization Using a DNA/Protein Molecular Staple, Presented by Lara M., Monash UniversityB080: Discovery of T-Cell Receptor Mimic Antibody Derived T-Cell Engager, Presented by Erica F., Nona BiosciencesB081: Enabling Fast Discovery of VHHs for Radioligand Therapy, Presented by Alexandra L. & Luca S., Novartis Pharma AGB082: Cell Free Expression of E3 Ubiquitin Ligases to Accelerate Target Protein Degradation Studies, Presented by Suzanne F., NucleraB083: Screen, Scale, Capture, Characterize: Rapid Protein Production and Characterization of Drug-Target Interactions, Presented by Chiara G., NucleraB084: AbiProt: A Breakthrough Technology for Identification of Antigenic Regions on Challenging Transmembrane Proteins, Presented by Anaswara A., Oblique Therapeutics ABB085: High Throughput Hydrophobicity and Polyreactivity Assays for 6His-Tagged Proteins, Presented by Aris P., PAIA Biotech GmbHB086: Establishing an Untargeted Metabolomics Workflow for Analysis of Spent Media by LC-MS, Presented by Paul G., PharmaronB087: Directed Luck®: Transposase Targeting and Transposon Design Push Expression Beyond Limits, Presented by Thomas R., ProBiogenB088: Machine-Learning Guided Engineering of Nivolumab for Superior Stability and Solubility, Presented by Norio H., RevolKa Ltd.B089: Application of Gene Editing Technologies to Improve Biotherapeutic Manufacturing, Presented by Neha M., RevvityB090: Integration of Next-Generation Transposon Vectors with Novel Host Cell Lines, Presented by Alex O., RevvityB091: CHOSOURCE™ ADCC+ Cell Line for Enhanced Therapeutic Potency, Presented by Jesus Z., RevvityB092: 2D-CEX-FcRn-MS to Study Structure/Function Relation of mAb Charge Variants, Presented by Thomas M., RIC BiologicsB093: Discovery and Characterization of Antibodies Against Challenging Membrane Protein Targets Using Salipro® Nano-Membrane Particles, Presented by Peter J., Salipro Biotech ABB094: Mechanistic Investigation of Antibody FcRn Interactions Using Confocal Microscopy, Presented by Tobias B., SanofiB095: Employing Automation and Machine Learning to Innovate Sartorius 4Cell® CHO Platform Cell Line Development Service, Presented by Jimit S., Sartorius Stedim Cellca GmbHB096: CHOice for Success: Mastering Media-Feed Screening and Analysis, Presented by Dennis K., Sartorius Xell GmbHB097: Development of Structural Analysis Services of Protein-Ligand Complexes in “Fast Track” Mode, Presented by Ekaterina B., SelvitaB098: Optimizing Freeze-Thaw Stability of Monoclonal Antibodies: Scale-Down Approaches, Presented by Andreia D., SmartfreezB099: How to Use Cold-Accelerated Studies to Model Aggregation of Antibodies During Storage, Presented by Miguel R., SmartfreezB100: High Throughput Functional Single Cell Analysis for Antibody Discovery and Cell Therapy, Presented by Yoshiharu H., Sony CorporationB101: AIntibody: An Experimentally-Validated In Silico Antibody Discovery Challenge, Presented by Frank E., Specifica, an IQVIA businessB102: A New Convenient Tool to Analyse Protein Glycosylation Based on FT-IR Spectroscopy, Presented by Allison D., Spectralys Biotech SRLB103: Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process, Presented by Maryam A., Sphere FluidicsB104: Detecting Particles for Root Cause Analysis: Distinguishing and Quantifying Surfactant Degradation Products, Silicone Oil and Protein Aggregates, Presented by Laura P., Spheryx, Inc.B105: Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs, Presented by Joshua G., Sygnature DiscoveryB106: Efficient Generation, B Cell Isolation, and High-Throughput Production for Monoclonal Antibodies, Presented by Giuseppe R., Takis SrlB107: Masking of Antibodies Using an Calmodulin-Derived Affinity Lock Approach, Presented by Adrian B., Technical University of DarmstadtB108: Enhanced Targeting Approach for NKp30-Based NK Cell Engagers, Presented by Lexane F., Technical University of DarmstadtB109: Using Protein Geometry to Optimize Cytotoxicity and the Cytokine Window of a ROR1 Specific T Cell Engager, Presented by Felix G., Technical University of DarmstadtB110: Taming IL 12: Engineering of Bispecific Antibody Based IL 12 Mimetics with Biased Agonism Capacities, Presented by Britta L., Technical University of DarmstadtB111: Engineering Bispecific Antibodies Targeting CD89 for Innate Immune Cell-Mediated Tumor Eradication, Presented by Felix M., Technical University of DarmstadtB112: A Genetic Strategy for the Conversion of Therapeutic mAbs into Immune Cell Recruiting Bispecifics, Presented by Paul P., Technical University of DarmstadtB113: Patterns of Conformational, Colloidal and Time-Dependent Stability for the Categorisation of Therapeutic Monoclonal Antibodies, Presented by Deniz S., Technical University of MunichB114: Detective’s Toolbox: Investigating Polysorbate Degradation Pathways, Presented by Michal R., ten23 health AGB115: Power Meets Precision | with Expi™ Protein Expression Systems and GeneArt HTP Antibody Production, Presented by Richard A., Thermo Fisher ScientificB116: Machine-Learning-Assisted Multiple Maturation of Antibody Fragment: Simultaneous Improvement of Target-Binding, Bacterial Expression, and Thermal Stability, Presented by Mitsuo U., Tohoku UniversityB117: Employing Membrane-Bound E3 Ligases for Targeted Degradation of Cell Surface Proteins Using Heterobispecific Antibodies (SureTACs), Presented by Michiel B., Universitair Medisch Centrum UtrechtB118: Engineering Recombinant Human Vaults to Target Cancer Stem Cells, Presented by Roger FP., Universitat Autònoma de BarcelonaB119: Optimization of Protein Solubility and Recovery of Precipitated Proteins, Presented by Mercedes M., Universitat Autònoma de BarcelonaB120: Aggrescan4D: Structure-Informed Analysis of pH-Dependent Protein Aggregation, Presented by Giulia P., Universitat Autònoma de BarcelonaB121: A Novel Structure-Driven Strategy for Parkinson's Disease Immunotherapy, Presented by Marc EA., Universitat Autònoma de BarcelonaB122: Validating Macrophage Targets for CAR-M Delivery, Presented by Sam D., University College LondonB123: AsEP: Benchmarking Deep Learning Methods for Antibody-Specific Epitope Prediction, Presented by ChuNan L., University College LondonB124: Tuning ProteinMPNN to Reduce Protein Visibility via MHC Class I Through Direct Preference Optimization, Presented by Hans-Christof G., University of EdinburghB125: Cats naturally infected with SARS-CoV-2: A potential source for developing antibodies against COVID-19 and future outbreaks, Presented by Isa M., University of LisbonB126: Generation of Biepitopic Antibodies with Intrinsic Agonism for Activating Tumor Necrosis Factor Receptors, Presented by Namir K., University of MichiganB127: Ultra-Efficient and Long-Lived Delivery of Cytokines to the CNS, Presented by Wade K., University of MichiganB128: Negative Data Composition Affects Machine Learning Generalization and Biological Rule Discovery, Presented by Aygul M., University of OsloB129: Design, Stabilize, Design: Using a Variety of Machine Learning Tools to Create De Novo TLRs and Their Binders, Presented by Cameron C., University of WashingtonB130: Evolving E3 Ligase Towards Recognising Novel Substrates for Targeted Protein Degradation, Presented by Sasha M., University of Zurich (UZH)B131: Harnessing Yeast for Antibody Drug Discovery and Development, Presented by Royan AS., VIB-UGent Center for Medical BiotechnologyB132: Examples of Qualitative and Quantitative Potential of Intact Protein LC-MS, Presented by Waltteri H., VTT Technical Research Centre of FinlandB133: High Throughput Cysteinylation Screening at mAb Subunit Level Using LC-MS Monitoring Workflow , Presented by Guillaume B., Waters CorporationB134: Simple and Automatable Sample Preparation for Tryptic Peptide Mapping with the PeptideWorks Kit, Presented by Antonia W., Waters CorporationB135: This, That, and the Other – Combining Primary, Secondary, and Tertiary Signals with Immune Cell Engagers to Supercharge Anti-Tumor Immunity, Presented by Winfried E., WuXi BiologicsB136: Optimizing Bispecific Antibody Production for Higher Titer and Purity Across Diverse Formats, Presented by Lorenz F., WuXi BiologicsB137: Generation and Engineering of Potent Single Domain Antibody-Based Bispecific IL-18 Mimetics, Presented by Laura U., Technical University of DarmstadtB138: Targeting LIFR as a Novel Therapeutic Approach for Fibrosis and Cancer Immunotherapies, Presented by Yunju J., Kyung Hee University B139: Seamless Integration of a Universal Epitope into Recombinant TCRs for Tagging and Tracking of TCR-T Cells Expressing 3S TCRs, Presented by Kanuj M., Medigene Immunotherapies GmbHB140: On-Target – Prioritizing Specificity During T Cell Engager Discovery Against Peptide:HLA Antigens, Presented by Mark T., Imuno TherapeuticsV1: Nanobody Tools for the Capture and Analysis of Cytokines and Immunoglobulins, Presented by Christian LW., ChromoTek GmbHV2: Nanobody-Based Tools for In-Depth Research of Immuno-Oncology Targets, Presented by Sabrina W., ChromoTek GmbH  </div> </div></div> </div> <div class="col-sm-3"> <div id="Contentplaceholder1_T14051A0F003_Col01" class="sf_colsIn pad-lr" data-sf-element="Column 2" data-placeholder-label="Column 2"><div class='sfContentBlock'> <a target="_blank" href="/docs/librariesprovider8/ics/24/pge24.ics?sfvrsn=72f8204e_1&download=true" title="Outlook"><img src="/images/default-source/social/calendar-gray.png?sfvrsn=91696e36_6" title="Outlook" alt="Outlook" class="social-icon" /></a> <a href="https://www.facebook.com/PEGSummit" target="_blank" title="Facebook"><img src="/images/default-source/social/facebook-gray.png?sfvrsn=35d4a48c_4" title="Facebook" alt="Facebook" class="social-icon" /></a> <a href="https://www.linkedin.com/groups/1830195/" target="_blank" title="LinkedIn"><img src="/images/default-source/social/linkedin-gray.png?sfvrsn=ed70471e_4" title="LinkedIn" alt="LinkedIn" class="social-icon" /></a> <a href="https://twitter.com/PEGSboston" target="_blank" title="Twitter"><img src="/images/default-source/social/twitter-gray.png?sfvrsn=bac909e7_7" title="Twitter" alt="Twitter" class="social-icon" /></a> <div class="sidebar-hashtag">#PEGSEurope </div><hr /><div><a href="https://register.cambridgeinnovationinstitute.com/reg/pge"><img src="/images/librariesprovider8/home/24/register-today-rc.png?sfvrsn=a325bb55_8" class="imageResize" alt="Register Early for Maximum Savings" /></a></div><div class="sidebar-item"><a href="/2024-brochure-download-form"><img src="/images/librariesprovider8/home/24/download-brochure-rc.png?sfvrsn=7062d93b_2" class="imageResize" alt="Download Brochure" /></a></div><div class="sidebar-item"><a href="/search"><img src="/images/librariesprovider8/home/24/search-agenda-rc.png?sfvrsn=a6f56dd7_5" class="imageResize" alt="Download Brochure" /></a></div><div class="sidebar-item"><a href="/poster-titles"><img src="/images/librariesprovider8/home/24/poster-rc.png?sfvrsn=8290ae8c_2" class="imageResize" alt="Present a poster" /></a></div><hr /> <div class="text-center"><a href="/sponsors" data-sf-ec-immutable="">VIEW ALL SPONSORS</a> <div class="text-center pad-top"><a href="/media-partners" data-sf-ec-immutable="">VIEW MEDIA PARTNERS</a> </div><hr /></div> </div> <div > <div class="sf-Long-text" >Conference Programs<img src="/images/librariesprovider8/home/24/pge-icons_pge-engineering-eyebrow.png?sfvrsn=4c94b9a4_1" title="Engineering" alt="Engineering" class="imageResize" /><div><ul><li><a href="/phage-display" data-sf-ec-immutable="">Display of Biologics</a> </li><li><a href="/engineering-antibodies" data-sf-ec-immutable="">Engineering Antibodies</a> </li><li><a href="/machine-learning-part2" data-sf-ec-immutable="">Machine Learning: Part 2</a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-targets-eyebrow.png?sfvrsn=aeecb1c6_1" title="Targets" alt="Targets" class="imageResize" /><ul><li><a href="/antibody-based-cancer-therapies" data-sf-ec-immutable="">Antibody-Based Therapies</a> </li><li><a href="/emerging-targets" data-sf-ec-immutable="">Emerging Targets & Approaches</a> </li><li><a href="/membrane-proteins" data-sf-ec-immutable="">Membrane Protein Targets</a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-bispecifics-eyebrow.png?sfvrsn=1815c3ef_1" title="Bispecifics" alt="Bispecifics" class="imageResize" /><ul><li><a href="/bispecific-safety-efficacy" data-sf-ec-immutable="">Safety & Efficacy</a> </li><li><a href="/advancing-bispecifics" data-sf-ec-immutable="">Advancing Multispecifics</a> </li><li><a href="/engineering-bispecifics" data-sf-ec-immutable="">Engineering Bispecifics</a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-immunotherapy-eyebrow.png?sfvrsn=ff126dc9_1" title="Immunotherapy" alt="Immunotherapy" class="imageResize" /><ul><li><a href="/tumour-microenvironment" data-sf-ec-immutable="">Modulating the TME</a> </li><li><a href="/car-t-innovations" data-sf-ec-immutable="">Innovative CAR T Therapy</a> </li><li><a href="/next-generation-immunotherapies" data-sf-ec-immutable="">Next-Gen Immunotherapies</a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-analytical-eyebrow.png?sfvrsn=c472cb2c_1" title="Analytical" alt="Analytical" class="imageResize" /><ul><li><a href="/optimisation-developability" data-sf-ec-immutable="">Optimisation & Developability</a> </li><li><a href="/characterising-biotherapeutics" data-sf-ec-immutable="">Analytical Characterisation</a> </li><li><a href="/protein-stability" data-sf-ec-immutable="">Protein Stability & Formulation </a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-expression-eyebrow.png?sfvrsn=ea1913a9_1" title="Expression" alt="Expression" class="imageResize" /><ul><li><a href="/systems-engineering" data-sf-ec-immutable="">Data Science & Engineering</a></li><li><a href="/optimising-protein-expression" data-sf-ec-immutable="">Optimising Expression</a></li><li><a href="/protein-process-development" data-sf-ec-immutable="">Process Development</a></li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-machine-learning-eyebrow.png?sfvrsn=b0bed8ca_1" class="imageResize" alt="Machine Learning" /><ul><li><a href="/PEGS-Europe-Training-Seminars" data-sf-ec-immutable="">Intro to Machine Learning</a> </li><li><a href="/machine-learning" data-sf-ec-immutable="">Machine Learning: Part 1</a> </li><li><a href="/machine-learning-part2" data-sf-ec-immutable="">Machine Learning: Part 2</a> </li></ul><img src="/images/librariesprovider8/home/24/pge-icons_pge-oncology-eyebrow.png?sfvrsn=abc93b1e_1" class="imageResize" alt="Oncology" /><ul><li><a href="/antibody-based-cancer-therapies" data-sf-ec-immutable="">Antibody-Based Therapies</a> </li><li><a href="/engineering-conjugates" data-sf-ec-immutable="">Engineering Conjugates</a> </li><li><a href="/next-generation-immunotherapies" data-sf-ec-immutable="">Next-Gen Immunotherapies</a> </li></ul><hr /><div><a href="/short-courses"><img src="/images/librariesprovider8/home/24/short-courses.png?sfvrsn=87846383_1" class="imageResize" alt="Short Courses" /></a></div><div class="sidebar-item"><a href="/PEGS-Europe-Training-Seminars"><img src="/images/librariesprovider8/home/24/training-seminars.png?sfvrsn=3cd22bc9_1" class="imageResize" alt="Training Seminars" /></a></div><hr />Related Event<a href="https://www.biologicsummit.com/" target="_blank"><img src="/images/librariesprovider8/side-bar/24/aibp25-400x175.jpg?sfvrsn=8c29de38_1" class="imageResize" alt="Bioloigics Summit 2025 - San Diego, CA" /></a> </div></div> </div></div> </div> </div> </div> </div> </div> <footer> <div > <div class="sf-Long-text" ><a href="https://register.cambridgeinnovationinstitute.com/reg/pge"><img src="/images/librariesprovider8/home/24/pge-banner-cta-final-days-1920x85.jpg?sfvrsn=7480aa37_8" alt="Register" class="imageResize" /></a></div> </div> <div > <div class="sf-Long-text" ><div class="footer"><div class="container"><div class="row"><div class="col-sm-3 col-xs-12"><div class="footer-small"><div class="footer-small-inner"><img alt="CHI | Cambridge HealthTech Institute" class="CII-footer" src="/UploadedImages/CHI-logo.png" data-sf-ec-immutable="" /> 250 First Avenue, Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 E: <a href="mailto:chi@healthtech.com?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">chi@healthtech.com</a> <div class="row"><div class="col-sm-12 footer-social"><a href="https://twitter.com/CHI_Healthtech" data-sf-ec-immutable=""><img src="/images/default-source/social/twitter-gray.png?sfvrsn=bac909e7_7" alt="" class="footer-social-icons" /></a> <a href="https://www.linkedin.com/company/cambridge-healthtech-institute" data-sf-ec-immutable=""><img src="/images/default-source/social/linkedin-gray.png?sfvrsn=ed70471e_4" class="footer-social-icons" alt="" /></a> <a href="https://www.facebook.com/HealthtechConferences" data-sf-ec-immutable=""><img src="/images/default-source/social/facebook-gray.png?sfvrsn=35d4a48c_4" class="footer-social-icons" alt="" /></a> </div></div></div></div></div><div class="col-sm-4 footer-border hidden-xs"><div class="row"><div class="col-sm-12">Life Science Portals</div><div class="col-sm-6"><a href="http://biologicaltherapeutics.cambridgeinnovationinstitute.com/home">Biological Therapeutic Products</a><a href="http://biomarkers.cambridgeinnovationinstitute.com/home">Biomarkers & Diagnostics</a><a href="http://biopharmastrategy.cambridgeinnovationinstitute.com/home">Biopharma Strategy</a><a href="https://bioprocessing.cambridgeinnovationinstitute.com/home">Bioprocess & Manufacturing</a><a href="http://chemistry.cambridgeinnovationinstitute.com/home">Chemistry</a><a href="http://clinicaltrials.cambridgeinnovationinstitute.com/home">Clinical Trials & Translational Medicine</a><a href="http://druganddevice.cambridgeinnovationinstitute.com/home">Drug & Device Safety</a></div><div class="col-sm-6"><a href="http://drugdevelopment.cambridgeinnovationinstitute.com/home">Drug Discovery & Development</a><a href="http://drugtargets.cambridgeinnovationinstitute.com/home">Drug Targets</a><a href="http://healthcare.cambridgeinnovationinstitute.com/home">Healthcare</a><a href="http://it.cambridgeinnovationinstitute.com/home">IT, AI, ML & Informatics</a><a href="http://techtools.cambridgeinnovationinstitute.com/home">Technology & Tools For Life Science</a><a href="http://therapeutics.cambridgeinnovationinstitute.com/home">Therapeutic Indications</a><a href="https://www.cambridgeinnovationinstitute.com/vip-series" data-sf-ec-immutable="">Venture, Innovation & Partnering</a></div></div></div><div class="col-sm-3 footer-border hidden-xs">CHI Divisions<a href="https://www.healthtech.com/?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">Conferences</a><a href="https://www.insightpharmareports.com/" data-sf-ec-immutable="">Reports & Market Research</a><a href="https://www.barnettinternational.com/" data-sf-ec-immutable="">Barnett Educational Services</a><a href="https://www.healthtech.com/publishing" data-sf-ec-immutable="">News & Advertising</a><a href="https://proservices.healthtech.com/?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">Professional Services</a></div><div class="col-sm-2 footer-border hidden-xs">Corporate Information<a href="https://www.cambridgeinnovationinstitute.com/" data-sf-ec-immutable="">Cambridge Innovation Institute</a><a href="https://www.cambridgeinnovationinstitute.com/Executive-Team/" data-sf-ec-immutable="">Executive Team</a><a href="https://www.cambridgeinnovationinstitute.com/Testimonials/" data-sf-ec-immutable="">Testimonials</a><a href="https://www.cambridgeinnovationinstitute.com/mailing-list.html" data-sf-ec-immutable="">Mailing List</a><a href="https://www.cambridgeinnovationinstitute.com/Careers/" title="Careers" data-sf-ec-immutable="">Careers</a><hr /><a href="https://www.cambridgeinnovationinstitute.com/request-information" data-sf-ec-immutable="">Request Information</a><a href="https://www.cambridgeinnovationinstitute.com/Privacy-Policy/" data-sf-ec-immutable="">Privacy Policy</a></div></div></div></div></div> </div> </footer> <script type="text/javascript"> //<![CDATA[ window.__TsmHiddenField = $get('ctl04_TSM');;(function() { function loadHandler() { var hf = $get('ctl05_TSSM'); if (!hf._RSSM_init) { hf._RSSM_init = true; hf.value = ''; } hf.value += ';Telerik.Sitefinity.Resources, Version=14.2.7900.0, Culture=neutral, PublicKeyToken=b28c218413bdf563:en:ec7772cc-ee32-478e-8437-4242283bb12f:7a90d6a'; Sys.Application.remove_load(loadHandler); }; Sys.Application.add_load(loadHandler); })();//]]> </script> </form><script type="application/json" id="PersonalizationTracker"> {"IsPagePersonalizationTarget":false,"IsUrlPersonalizationTarget":false,"PageId":"6545f6d9-50d6-4f87-89f8-0384fed7b864"} </script><script type="text/javascript" src="/WebResource.axd?d=Oiw5o8i74rDb2VpVaCaMSouKRnJ2rn_cgRr8eXgFzWmU6yVv8fmvjGNlDReMboLSikSmK5y_KsDt9j-18b7ZqBNiz0-92AjY43-6qMcq4O__3MjW1Pd6kS68TTYuxCxnF4HnqcusO3ivgfHZzR9usujs8YAzvYku29ledrs3mezPir5ikBP0Pxh4nDmiJEk2WgW0YVPdsdMlu69MVd6jI94nvC3-40pMaRxtm9HTV2I1&t=637922505260000000"> </script><script type="text/javascript" src="/bower_components/js-url/url.min.js"></script><script type="text/javascript" src="/js/TrackClicks.js"></script><script type="text/javascript" src="/js/CrossDomainClient.js"></script></body> </html>